Christopher Morabito serves as Executive at Fulcrum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Morabito has executed 7 insider transactions totaling $257.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 1, 2024 involved selling 10,000 shares valued at $135.9K.
Christopher Morabito currently holds 10,000 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Morabito has been a net seller of FULC stock. They have purchased $10.1K and sold $247.3K worth of shares.
Christopher Morabito's most recent insider trade was on Apr 1, 2024, when they sold 10,000 shares at $13.59 per share.
Get notified when new Form 4 filings are submitted
| $3.87 |
| Planned |
| Jan 29, 2024 | ATXS | $35.6K | Option Exercise | 9,200 | $3.87 | Planned |
| Jan 29, 2024 | ATXS | $102.6K | Sale | 9,200 | $11.15 | Planned |
| Jan 26, 2024 | ATXS | $8.8K | Sale | 800 | $11.02 | Planned |
| Jan 26, 2024 | ATXS | $3.1K | Option Exercise | 800 | $3.87 | Planned |
| Jun 28, 2021 | FULC | $10.1K | Purchase | 1,100 | $9.16 | Discretionary |